PDS Biotechnology (PDSB) Tops Q1 EPS by 2c

PDS Biotechnology (NASDAQ: PDSB) reported Q1 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trump: 40-60% of chip manufacturing will be in the U.S. - CNBC Interview
• Correction: Kepler Cheuvreux Upgrades Siemens AG (SIE:GR) (SIEGY) to Hold